STOCK TITAN

Kiniksa Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 1:30 p.m. PT (4:30 p.m. ET). The presentation will be accessible via a live webcast on the company’s website, with a replay available within approximately 48 hours post-event. Kiniksa focuses on developing therapeutic medicines for diseases with significant unmet medical needs, featuring assets like ARCALYST®, KPL-404, and mavrilimumab, which aim to address underserved conditions by modulating immunological pathways.

Positive
  • None.
Negative
  • None.

HAMILTON, Bermuda, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s portfolio assets, ARCALYST®, KPL-404, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target underserved conditions, and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visit www.kiniksa.com.

ARCALYST® is a registered trademark of Regeneron Pharmaceuticals, Inc.

Every Second Counts! ®

Kiniksa Investor and Media Contact
Rachel Frank
(339) 970-9437
rfrank@kiniksa.com


FAQ

When is Kiniksa's presentation at the J.P. Morgan Healthcare Conference?

Kiniksa's presentation is on January 9, 2023, at 1:30 p.m. PT (4:30 p.m. ET).

Where can I watch Kiniksa's presentation?

The presentation will be available via a live webcast on Kiniksa's website.

What time will Kiniksa's presentation start?

Kiniksa's presentation will start at 1:30 p.m. Pacific Time.

What company is presenting at the J.P. Morgan Healthcare Conference?

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) is presenting.

What is Kiniksa Pharmaceuticals focused on?

Kiniksa specializes in developing therapeutic medicines for diseases with significant unmet medical needs.

Kiniksa Pharmaceuticals International, plc

NASDAQ:KNSA

KNSA Rankings

KNSA Latest News

KNSA Stock Data

1.51B
39.78M
4.15%
98%
5.84%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
LONDON